The Securities and Exchange Board of India (SEBI) has approved IPOs for Alpine Texworld, Anjali Labtech, Integris Medtech, and APPL Containers. These companies, spanning textiles, lab-grown diamonds, medical technology, and industrial packaging, plan to list on BSE and NSE, signaling strong momentum in India’s capital markets across diverse sectors.
On February 20–22, 2026, SEBI issued final observations clearing four new mainboard IPOs. The approvals cover Integris Medtech (medical technology), Anjali Labtech (lab-grown diamonds), APPL Containers (industrial packaging), and Alpine Texworld (textiles).
Among them, Integris Medtech, backed by Everstone Capital, plans to raise ₹925 crore via fresh issue alongside an offer-for-sale of 2.16 crore shares. The other three companies are expected to announce fundraising details soon, with all shares proposed to be listed on BSE and NSE.
Analysts highlight that these IPOs reflect investor appetite across manufacturing, healthcare, and consumer sectors, reinforcing India’s position as a vibrant hub for capital market activity.
Major Takeaways
-
SEBI approved IPOs for Alpine Texworld, Anjali Labtech, Integris Medtech, and APPL Containers
-
Integris Medtech to raise ₹925 crore via fresh issue plus OFS of 2.16 crore shares
-
All four IPOs to list on BSE and NSE
-
Sectors covered: textiles, lab-grown diamonds, medical technology, industrial packaging
-
Approvals issued between Feb 13 and Feb 20, 2026
-
Reflects strong investor interest in diverse industries
Conclusion
The approval of these four IPOs underscores India’s robust capital market momentum, with diverse sectors tapping into public funding. As Alpine Texworld, Anjali Labtech, Integris Medtech, and APPL Containers prepare to launch, investors can expect fresh opportunities across innovation-driven and traditional industries.
Sources: Moneycontrol, Upstox News, IPO Watch